首页> 外文期刊>Neoplasma: Journal of Experimental and Clinical Oncology >Contemporary trends in in vivo and in vitro testing of chemical carcinogens.
【24h】

Contemporary trends in in vivo and in vitro testing of chemical carcinogens.

机译:化学致癌物体内和体外测试的当代趋势。

获取原文
获取原文并翻译 | 示例
           

摘要

In the sixties of the last century it was realized that many human cancers are caused by environmental carcinogens and that the best way how to reduce cancer is first to identify in environment chemical carcinogens and second to prevent people from being exposed to such carcinogens. Epidemiological studies are probably the only way to confirm human carcinogenesis, however, this approach is so retrospective that carcinogens can be identified only after many victims have appeared. Carcinogenicity testing in long-term, medium-term, and short-term studies is therefore the only way for the prospective identification of possible human carcinogens. End-points of interest in a carcinogenicity study are primarily preneoplastic and neoplastic changes, but also include degree of malignancy, time to tumor appearance, multiplicity of (pre)neoplasia, and occurence of metastases. Long-term bioassays are designed and conducted to detect all of these end-points. Medium-term bioassays are mainly based on the detection of putative preneoplastic lesions and short-term tests can provide very important information concerning genotoxic effects of studied compounds.
机译:在上个世纪六十年代,人们认识到许多人类癌症是由环境致癌物引起的,减少癌症的最佳方法首先是在环境化学致癌物中进行鉴定,其次是防止人们暴露于这种致癌物。流行病学研究可能是确认人类致癌作用的唯一方法,但是,这种方法具有追溯力,以致只有在许多受害者出现后才能鉴定出致癌物。因此,长期,中期和短期研究中的致癌性测试是前瞻性鉴定可能的人类致癌物的唯一方法。致癌性研究的主要关注终点是肿瘤发生前和肿瘤发生的变化,但还包括恶性程度,出现肿瘤的时间,(前)肿瘤形成的多样性以及转移的发生。设计并进行了长期生物测定以检测所有这些终点。中期生物测定法主要基于对假定的肿瘤前病变的检测,短期测试可以提供有关所研究化合物的遗传毒性作用的非常重要的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号